Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (411-420 of 662) with videos related to

Pageof 67
Sort By:
Leukemia|January 26, 2019
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemiaSebastian Kollmann, Eva Grundschober, Barbara Maurer, et al.
International Journal of Molecular Sciences|August 6, 2020
Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO SubgroupsBogusław Nedoszytko, Marta Sobalska-Kwapis, Dominik Strapagiel, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Investigative Dermatology|December 15, 2007
The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gammaIrene Mittermann, Renate Reininger, Maya Zimmermann, et al.
Plos One|October 17, 2013
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLUwe Rix, Jacques Colinge, Katharina Blatt, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Experimental Hematology|August 8, 2007
Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cellsKaroline V Gleixner, Laura Rebuzzi, Matthias Mayerhofer, et al.
British Journal of Haematology|July 23, 2024
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxisBarbora Weinbergerová, Jiří Mayer, Tomáš Kabut, et al.
Wiener Klinische Wochenschrift|July 21, 2010
[Tumor stem cell research - basis and challenge for diagnosis and therapy]Heidrun Karlic, Harald Herrmann, Axel Schulenburg, et al.
Leukemia & Lymphoma|June 7, 2006
Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemiaKaroline Sonneck, Stefan Florian, Alexandra Böhm, et al.
Pageof 67

Showing results (411-420 of 662) with videos related to

Sort By:
Pageof 67
Leukemia|January 26, 2019
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemiaSebastian Kollmann, Eva Grundschober, Barbara Maurer, et al.
International Journal of Molecular Sciences|August 6, 2020
Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO SubgroupsBogusław Nedoszytko, Marta Sobalska-Kwapis, Dominik Strapagiel, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Investigative Dermatology|December 15, 2007
The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gammaIrene Mittermann, Renate Reininger, Maya Zimmermann, et al.
Plos One|October 17, 2013
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLUwe Rix, Jacques Colinge, Katharina Blatt, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Experimental Hematology|August 8, 2007
Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cellsKaroline V Gleixner, Laura Rebuzzi, Matthias Mayerhofer, et al.
British Journal of Haematology|July 23, 2024
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxisBarbora Weinbergerová, Jiří Mayer, Tomáš Kabut, et al.
Wiener Klinische Wochenschrift|July 21, 2010
[Tumor stem cell research - basis and challenge for diagnosis and therapy]Heidrun Karlic, Harald Herrmann, Axel Schulenburg, et al.
Leukemia & Lymphoma|June 7, 2006
Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemiaKaroline Sonneck, Stefan Florian, Alexandra Böhm, et al.
Pageof 67